Cell line · CVCL_1576
NCI-H660
Cancer cell line, Homo sapiens. Prostate small cell carcinoma. 44 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. NCI-H660. Cell lines, record CVCL_1576. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_1576
On this page
Cell line
As Cellosaurus gives it.
- Name
- NCI-H660
- Accession
- CVCL_1576
- RRID
- RRID:CVCL_1576
- Synonyms
- H660, H-660, NCIH660, NCI660
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 63Y
- Category
- Cancer cell line
- Diseases
- Prostate small cell carcinoma (NCIt C6766)
- Derived from
- Cervical lymph node (metastatic)
- Entry created
- 2012-04-04
- Entry updated
- 2025-04-10
Source Cellosaurus
Problems1
| Problem | Cellosaurus's note |
|---|---|
| Caution | Was originally published as originating from a small cell lung carcinoma (PubMed=2985257), but was later shown to originate from a prostate small cell carcinoma (PubMed=2569043). |
Source Cellosaurus
Papers44
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Vitronectin Enrichment in Prostate Cancer Liver Metastases Promotes Adhesion and Survival. | Cancer Res Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A stress-adaptive lipid kinase axis defines metabolic vulnerabilities in neuroendocrine prostate cancer. | Cancer Cell | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A Stress-Adaptive Lipid Kinase Axis Defines Metabolic Vulnerabilities in Neuroendocrine Prostate Cancer. | bioRxiv | 2026 | Its Methods give the RRID and name the line | PubMed | |
| CXCR2-mediated metabolic interaction between prostate cancer cells and the immunosuppressive tumor microenvironment. | J Immunother Cancer | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting arginine metabolism overcomes chemotherapy resistance in aggressive-variant prostate cancers. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting the ferritinophagy-lysosome axis as a therapeutic vulnerability in gastroenteropancreatic neuroendocrine tumors. | Cell Rep Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming. | Cancer Discov | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Preclinical Activity of the DLL3-Targeted T-cell Engager MK-6070 in Neuroendocrine Prostate Cancer. | Mol Cancer Ther | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Clinical significance of stratifying prostate cancer patients through specific circulating genes. | Mol Oncol | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Discovery of a peptide proteolysis-targeting chimera (PROTAC) drug of p300 for prostate cancer therapy. | EBioMedicine | 2024 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 44
See all 44 papersRelatives0
None in this release.
Cell banks1
| Cell bank | Catalog number | Status |
|---|---|---|
| ATCC | CRL-5813 |
Source ATCC
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_1576
GET https://conductscience.org/api/cell-lines/v1/CVCL_1576/papers?page=2